A systematic review and meta-analysis of the incidence and predictors of blood transfusion in breast reconstruction post TRAM (transverse rectus abdominus myocutaneous) flap and DIEP (deep inferior epigastric perforator) flap

S. Sepehripour, G. Filobbos, C. Malata
2015 International Journal of Surgery  
option, with 40% willing to have neoadjuvant endocrine therapy to facilitate this. Only 14% would have considered neoadjuvant chemotherapy with the same aim. Despite our BCS patients having to travel a considerable distance daily for radiotherapy, only 4% found it problematic. Eightyeight percent of patients who had BCS were happy with their treatment decision, 72% being happy with the cosmetic outcome. Conclusion: BCS is something that patients aged 70+ are interested in considering. More than
more » ... sidering. More than a third of mastectomy patients would be willing to take neoadjuvant endocrine therapy to facilitate BCS. Aim: To explore the presentation of the over 70s with breast cancer, along with attitudes towards screening. Methods: A questionnaire was sent to patients aged 70+ at breast cancer diagnosis in NHS Lanarkshire between 2006 and 2013. This detailed reasons and timing of presentation, in addition to thoughts about screening. Results: Three hundred and fifty-two questionnaires were sent with a 65% response rate. Sixty-four percent routinely examined themselves with 70% identifying a lump themselves. Distressingly only 36% were aware of the other signs/ symptoms of breast cancer. The majority of women sought medical attention early, with 39% presenting within days, personal concern was the greatest prompt (68%). Eighty-three percent routinely attended screening when invited, a further 3% willing to attend once over 70. The majority (60%) were not aware that they could opt into the screening service when over 70. Conclusion: Despite the belief that older women are less breast aware most of our patients routinely examined themselves, identified pathology, and promptly sought medical advice. Despite most women having no knowledge of other signs and symptoms of breast cancer. Our cohort has also shown that they are keen to continue screening over the age of 70 if it was routinely offered.
doi:10.1016/j.ijsu.2015.07.089 fatcat:rnrekeq77reklap5cq6tbwseye